Pluri Inc.

Biotechnology company · Haifa, Israel · Nasdaq: PLUR

Pluri Inc. is a biotechnology company headquartered in Haifa, Israel. Its shares trade on Nasdaq under the ticker PLUR. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Pluri at a glance

Typebiotechnology company

HeadquartersHaifa, Israel

Stock listingNasdaq: PLUR

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1158780

What does Pluri do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $3.5 million sold (2025).

Frequently asked questions about Pluri

Where is Pluri headquartered?

Pluri Inc. is headquartered in Haifa, Israel.

What does Pluri do?

Pluri Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Pluri a public company?

Yes. Pluri Inc. trades on Nasdaq under the ticker PLUR.

Similar companies

Bonus Biogroup Ltd.Haifa, Israel
Entera Bio Ltd.Jerusalem, Israel
Compugen LtdH̱olon, Tel Aviv, Israel
Scinai Immunotherapeutics Ltd.Jerusalem, Israel
Gamida Cell Ltd.Jerusalem, Israel
Silexion Therapeutics CorpRamat Gan, Tel Aviv, Israel
Atox Bio Inc.Ness Ziona, Central District, Israel
Check-Cap Ltd‘Isfiyā, Haifa, Israel

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences